Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:00 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 553–576 of 1,326 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Validation Clear all

Conditions: Colorectal Cancer, Colorectal Neoplasms, Colorectal Adenocarcinoma, Colorectal Cancer Stage I, Colorectal Cancer Stage IV, Colorectal Cancer Stage II, Colorectal Cancer Stage III, Colorectal Neoplasms Malignant
Interventions: ENCODE; Diagnostic Test
Lead sponsor: City of Hope Medical Center; Other
Eligibility: 18 Years to 50 Years
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Duarte, California

Conditions: Workflow, Nursing
Interventions: RTLS current tag, RTLS tag revised; Device
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Firearm Injury
Interventions: Not listed
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 24 Years
Enrollment: 1,506 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 4
States / cities: Flint, Michigan • Philadelphia, Pennsylvania • Seattle, Washington

Conditions: Arteriovenous Malformations
Interventions: CT angiography; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 10 Years to 120 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Human Immunodeficiency Virus (HIV)
Interventions: Skyn Monitor Lab Session 1, Skyn Monitor Field Test with EMA App, Skyn Monitor Lab Session 2; Device
Lead sponsor: University of Florida; Other
Eligibility: 21 Years to 64 Years
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 2
States / cities: Gainesville, Florida

Conditions: Determine Validity of Concept of Using Hemoglobin Dilution to Assess/Measure Blood Volume.
Interventions: Blood Volume Dilution; Drug
Lead sponsor: Kai Schoenhage; Other
Eligibility: 18 Years to 50 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Amputation; Traumatic, Hand
Interventions: Point Partial; Device
Lead sponsor: Point Designs; Industry
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 2
States / cities: Aurora, Colorado • Lafayette, Colorado

Conditions: Cultural Competence
Interventions: Cultural Competence Education module; Other
Lead sponsor: Texas Woman's University; Other
Eligibility: Not listed
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: San Marcos, Texas

Conditions: Cancer Risk, Breast Cancer Risk
Interventions: Magnetic resonance imaging (MRI), Artificial Intelligence (AI); Procedure · Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 40 Years to 89 Years · Female only
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 4
States / cities: San Diego, California • San Francisco, California • Chicago, Illinois + 1 more

Conditions: Coronary Artery Disease
Interventions: CardioSond Cardiac Sonospectrographic Analyzer; Device
Lead sponsor: SonoMedica, Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Cardiac Output
Interventions: Not listed
Lead sponsor: Transonic Systems Inc.; Industry
Eligibility: Up to 18 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Amputation; Traumatic, Hand
Interventions: Point Digit; Device
Lead sponsor: Point Designs; Industry
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Aurora, Colorado • Lafayette, Colorado

Conditions: Prostate Cancer
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older · Male only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Normal Physiology
Interventions: MRI; Device
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 18 Years to 45 Years
Enrollment: 550 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2032
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Skin Cancer
Interventions: Digital dermoscopy; Device
Lead sponsor: Barco NV; Industry
Eligibility: Not listed
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 2
States / cities: Chevy Chase, Maryland • Salem, Oregon

Conditions: NAFLD, NASH
Interventions: LiverFASt; Diagnostic Test
Lead sponsor: Fibronostics USA, Inc; Other
Eligibility: 18 Years to 80 Years
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Infiltration of Peripheral IV Therapy
Interventions: ivWatch Model 400 with Milky Way Sensor; Device
Lead sponsor: ivWatch, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Newport News, Virginia

Conditions: Bladder Cancer, Urothelial Carcinoma (UC), Hematuria, Upper Tract Urothelial Cancer
Interventions: Not listed
Lead sponsor: Convergent Genomics, Inc.; Network
Eligibility: 18 Years and older
Enrollment: 2,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2034
U.S. locations: 21
States / cities: Oceanside, California • San Diego, California • San Jose, California + 15 more

Conditions: Seizures, Motor, Seizures, Seizure Disorder, Epilepsy, Epileptic Seizures, Epileptic
Interventions: Motor Seizure Detection Algorithm (mSDA); Device
Lead sponsor: Overwatch Digital Health; Industry
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Lubbock, Texas

Conditions: Leukemia
Interventions: QUALMS-1 Questionnaire, FACT-An Questionnaire; Behavioral
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 6
States / cities: Tampa, Florida • Baltimore, Maryland • Boston, Massachusetts + 3 more

Conditions: Spinal Cord Injuries (SCI), Multiple Sclerosis
Interventions: Individualized reduction of falls (iROLL), Stopping Elderly Accidents, Deaths & Injuries (STEADI); Procedure
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Healthy Volunteers
Interventions: Rosuvastatin, Rosuvastatin (Inhibitor arm), Eltrombopag; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 64 Years
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: San Francisco, California

Conditions: To Determine the Safety and Validity of Venous Angioplasty and, Valvuloplasty in the Treatment of CCSVI. In Addition, it Will, Allow Researchers to Sub-classify Valve Morphology in Relation, to Treatment Success. This Will be Evidenced by Venous Patency, Forty-eight Hours by Doppler Ultrasound as Well as Clinical, Symptom Improvement.
Interventions: Not listed
Lead sponsor: Synergy Health Concepts, Inc.; Industry
Eligibility: 20 Years to 60 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Newport Beach, California

Conditions: MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease), Fibrosis and Cirrhosis of Liver, MetALD
Interventions: Not listed
Lead sponsor: Active Genomes Expressed Diagnostics, Corp; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Search by objective public record fields.

Early Onset Colorectal Cancer Detection

RTLS for Healthcare Process Validation

Clinical Screening for Firearm Violence Risk

Treating Arteriovenous Malformation With Stereotactic Radiosurgery Using CT Angiography for Treatment Planning

Alcohol Monitor Validation

Calculating Blood Volume by Dilution of Hemoglobin - Pilot Study

Validation of Point Partial User Needs With Partial Finger Amputees

Construct Validity, Responsiveness, and Demographic Predictors of the IAPCC-SV

Mirai-MRI: Validation of AI Models for Breast Cancer Risk

Comparison of Digital Electronic Stethoscope to Computed Tomography (CT) Angiography in Detection of Coronary Artery Disease

Accurate Measurement of Cardiac Output Using the Ultrasound Dilution Technique

Validation of User Needs of the Point Digit With Partial Hand Amputees

Validation of Software-based Fusion of Ultrasound and MRI Images of the Prostate

Development and Validation of Learning and Decision-Making Tasks

Development and Validation of a New Digital Dermatoscope in the United States

Validation of the LiverFASt Test and the Associated Fibrosis Staging Scores Compared to Liver Tissue Pathology Via Liver Biopsy

Milky Way Sensor: Device Validation for Infiltrated Tissues

Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer

Study to Validate Novel Seizure-Detection Algorithm

Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease

Fall Prevention Among People With Spinal Cord Injury and Multiple Sclerosis Who Use Wheelchairs and Scooters

Identification and Validation of Biomarkers for Breast Cancer Resistance Protein (BCRP)

Radiographic and Intravascular (IVUS) Evaluation of Venous Morphology During CCSVI Treatment

AGED Diagnostics Clinical Validation Study